Lyme Disease Testing Global Market Report 2025

Description

Lyme disease testing involves diagnostic methods used to identify infection with Borrelia burgdorferi, the bacterium responsible for Lyme disease, which is commonly transmitted via tick bites. The primary goal of Lyme disease testing is to ensure accurate diagnosis, particularly in individuals presenting symptoms such as fever, fatigue, and the distinctive bull's-eye rash.

The primary types of tests used in Lyme disease diagnostics include serological tests, nucleic acid tests, urine antigen tests, and others. Serological tests detect the presence of antibodies or antigens in a patient's blood to determine exposure to infections or immune responses. Common testing techniques include enzyme-linked immunosorbent assay (ELISA), Western blot, polymerase chain reaction (PCR), immunofluorescence assay (IFA), and others. Testing is applicable across different disease stages, including early Lyme disease, disseminated Lyme disease, chronic Lyme disease, and asymptomatic infection detection. Various sample types used include blood, urine, cerebrospinal fluid (CSF), and more. These diagnostic procedures are carried out by a range of end users, such as hospitals and clinics, diagnostic laboratories, home care settings, research institutions, and public health agencies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The lyme disease testing market research report is one of a series of new reports from The Business Research Company that provides lyme disease testing market statistics, including lyme disease testing industry global market size, regional shares, competitors with a lyme disease testing market share, detailed lyme disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the lyme disease testing industry. The lyme disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lyme disease testing market size has grown strongly in recent years. It will grow from $9.77 billion in 2024 to $10.68 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historic period can be attributed to the rising demand for early disease diagnosis, increased accessibility to advanced diagnostic technologies, a growing tick population driven by climate change, enhanced government funding for the control of vector-borne diseases, and the expansion of healthcare infrastructure in rural and endemic regions.

The lyme disease testing market size is expected to see strong growth in the next few years. It will grow to $15.11 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth during the forecast period can be attributed to the rising travel to Lyme-endemic areas, increased utilization of multiplex diagnostic technologies, a surge in outdoor recreational activities, growing demand for at-home testing kits, and heightened concerns about co-infections with other tick-borne illnesses. Key trends expected in the forecast period include progress in molecular diagnostic methods, advancements in biomarker discovery, technological innovations in point-of-care testing devices, developments in lab-on-a-chip (microfluidic) platforms, and improvements in immunoassay technologies.

The increasing prevalence of tick-borne illnesses is expected to drive the growth of the Lyme disease testing market. Tick-borne illnesses are diseases transmitted to humans through bites from infected ticks, which are small parasites commonly found in grassy, wooded, or rural areas. The demand for treatments and testing related to tick-borne illnesses is rising due to the expanding geographic distribution of ticks, largely influenced by climate change, resulting in greater exposure and infection rates. Since ticks are the primary vectors for Lyme disease, the increase in these illnesses highlights the need for early detection and accurate diagnosis. For example, in July 2024, the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported 71,346 cases of tick-borne diseases in 2022-up from 36,177 cases in 2021. As a result, the growing number of tick-borne illness cases is fueling the demand for Lyme disease testing.

Companies in the Lyme disease testing market are emphasizing technological innovations in diagnostic tools to improve test accuracy, decrease turnaround times, and support early-stage disease detection. These diagnostic tools include devices, kits, and technologies designed to identify the presence of Lyme disease by detecting antibodies, antigens, or genetic material associated with Borrelia burgdorferi, the bacteria responsible for the disease. For instance, in August 2024, EpitogenX Ltd., a UK-based biotechnology company, launched a new Lyme Disease Diagnostic Kit. This ELISA-based assay was developed using the company's proprietary EpitoGen platform and includes approximately 120 distinct Borrelia epitopes, offering high specificity and sensitivity. Designed for research use only (RUO), the kit enables early, strain-specific detection and can be adapted for various laboratory settings, providing enhanced diagnostic accuracy and deeper insights into Lyme disease.

In May 2024, T2 Biosystems Inc., a US-based in vitro diagnostics company, formed a partnership with ECO Laboratory to improve early Lyme disease detection. This collaboration focuses on advancing the development and clinical validation of the T2Lyme Panel, a molecular diagnostic test aimed at providing accurate and early detection of Lyme disease. The partnership utilizes ECO Laboratory's CLIA-certified facilities to broaden access to advanced tick-borne disease testing throughout the United States. ECO Laboratory is a US-based diagnostic service provider specializing in Lyme and other tick-borne illnesses.

Major players in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMERIEUX, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Everlywell, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Novatein Biosciences, and Lyme Diagnostics Ltd.

North America was the largest region in the lyme disease testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lyme disease testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lyme disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lyme disease testing market includes revenues earned by entities by providing services such as diagnostic test kit development, laboratory testing services, polymerase chain reaction (PCR)-based testing, serological testing, and point-of-care testing solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lyme Disease Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lyme disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lyme disease testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lyme disease testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Test Type: Serological Tests; Nucleic Acid Tests; Urine Antigen Tests; Other Test Types
2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA); Weste Blot; Polymerase Chain Reaction (PCR); Immunofluorescence Assay (IFA); Other Emerging Technologies
3) By Disease Stage: Early Lyme Disease; Disseminated Lyme Disease; Chronic Lyme Disease; Asymptomatic Lyme Disease Detection
4) By Sample Type: Blood; Urine; Cerebrospinal Fluid(CSF); Other Blood Samples
5) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Home Care Settings; Research Institutions; Public Health Organizations
Subsegments:
1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)
2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)
3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests
4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools
Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; Labcorp Holdings Inc.; Quest Diagnostics Incorporated; Eurofins Scientific; BIOMERIEUX; Quidel Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin S.p.A; Meridian Bioscience; Everlywell; Trinity Biotech; T2 Biosystems; IGeneX; Viramed Biotech AG; Ceres Nanosciences; Galaxy Diagnostics; Novatein Biosciences; Lyme Diagnostics Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37046

1. Executive Summary

2. Lyme Disease Testing Market Characteristics

3. Lyme Disease Testing Market Trends And Strategies

4. Lyme Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lyme Disease Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Lyme Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Lyme Disease Testing Market Growth Rate Analysis
5.4. Global Lyme Disease Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Lyme Disease Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Lyme Disease Testing Total Addressable Market (TAM)

6. Lyme Disease Testing Market Segmentation

6.1. Global Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serological Tests
Nucleic Acid Tests
Urine Antigen Tests
Other Test Types
6.2. Global Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme-Linked Immunosorbent Assay (ELISA)
Weste Blot
Polymerase Chain Reaction (PCR)
Immunofluorescence Assay (IFA)
Other Emerging Technologies
6.3. Global Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Early Lyme Disease
Disseminated Lyme Disease
Chronic Lyme Disease
Asymptomatic Lyme Disease Detection
6.4. Global Lyme Disease Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood
Urine
Cerebrospinal Fluid(CSF)
Other Blood Samples
6.5. Global Lyme Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Laboratories
Home Care Settings
Research Institutions
Public Health Organizations
6.6. Global Lyme Disease Testing Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme-Linked Immunosorbent Assay
Western Blot
Immunofluorescence Assay (IFA)
Line Immunoassay (LIA)
6.7. Global Lyme Disease Testing Market, Sub-Segmentation Of Nucleic Acid Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR)
Loop-Mediated Isothermal Amplification (LAMP)
Next-Generation Sequencing (NGS)
6.8. Global Lyme Disease Testing Market, Sub-Segmentation Of Urine Antigen Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lateral Flow Assay
Enzyme Immunoassay (EIA)
Immunoblot Urine Tests
6.9. Global Lyme Disease Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Culture-Based Tests
Tick-Borne Co-Infection Panels
Artificial Intelligence-Assisted Diagnostic Tools

7. Lyme Disease Testing Market Regional And Country Analysis

7.1. Global Lyme Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Lyme Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lyme Disease Testing Market

8.1. Asia-Pacific Lyme Disease Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lyme Disease Testing Market

9.1. China Lyme Disease Testing Market Overview
9.2. China Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lyme Disease Testing Market

10.1. India Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lyme Disease Testing Market

11.1. Japan Lyme Disease Testing Market Overview
11.2. Japan Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lyme Disease Testing Market

12.1. Australia Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lyme Disease Testing Market

13.1. Indonesia Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lyme Disease Testing Market

14.1. South Korea Lyme Disease Testing Market Overview
14.2. South Korea Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lyme Disease Testing Market

15.1. Western Europe Lyme Disease Testing Market Overview
15.2. Western Europe Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lyme Disease Testing Market

16.1. UK Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lyme Disease Testing Market

17.1. Germany Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lyme Disease Testing Market

18.1. France Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lyme Disease Testing Market

19.1. Italy Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lyme Disease Testing Market

20.1. Spain Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lyme Disease Testing Market

21.1. Eastern Europe Lyme Disease Testing Market Overview
21.2. Eastern Europe Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lyme Disease Testing Market

22.1. Russia Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lyme Disease Testing Market

23.1. North America Lyme Disease Testing Market Overview
23.2. North America Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lyme Disease Testing Market

24.1. USA Lyme Disease Testing Market Overview
24.2. USA Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lyme Disease Testing Market

25.1. Canada Lyme Disease Testing Market Overview
25.2. Canada Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lyme Disease Testing Market

26.1. South America Lyme Disease Testing Market Overview
26.2. South America Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lyme Disease Testing Market

27.1. Brazil Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lyme Disease Testing Market

28.1. Middle East Lyme Disease Testing Market Overview
28.2. Middle East Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lyme Disease Testing Market

29.1. Africa Lyme Disease Testing Market Overview
29.2. Africa Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lyme Disease Testing Market Competitive Landscape And Company Profiles

30.1. Lyme Disease Testing Market Competitive Landscape
30.2. Lyme Disease Testing Market Company Profiles
- 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis

31. Lyme Disease Testing Market Other Major And Innovative Companies

31.1. BIOMERIEUX
31.2. Quidel Corporation
31.3. Bio-Rad Laboratories Inc.
31.4. QIAGEN N.V.
31.5. DiaSorin S.p.A
31.6. Meridian Bioscience
31.7. Everlywell
31.8. Trinity Biotech
31.9. T2 Biosystems
31.10. IGeneX
31.11. Viramed Biotech AG
31.12. Ceres Nanosciences
31.13. Galaxy Diagnostics
31.14. Novatein Biosciences
31.15. Lyme Diagnostics Ltd.

32. Global Lyme Disease Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lyme Disease Testing Market

34. Recent Developments In The Lyme Disease Testing Market

35. Lyme Disease Testing Market High Potential Countries, Segments and Strategies

35.1 Lyme Disease Testing Market In 2029 - Countries Offering Most New Opportunities
35.2 Lyme Disease Testing Market In 2029 - Segments Offering Most New Opportunities
35.3 Lyme Disease Testing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer